Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MAC-001 by Macera Therapeutics for Gastric Cancer: Likelihood of Approval
MAC-001 is under clinical development by Macera Therapeutics and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...